ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

  • You are here:
  • Home
  • Reports
  • ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

IVF process involves forcing the production of follicles and eggs through ovulatory simulation, collection of matured eggs, fertilizing them outside the body and then transferring one or more fertilized eggs back into the uterus. With an expected CAGR rise of 12.68%, the Asia-Pacific in-vitro fertilization market continues to escalate in terms of revenue for the forecast period of 2018-2026.

ASIA PACIFIC IN-VITRO FERTILIZATION MARKET FORECAST 2018-2026

Asia Pacific In-vitro Fertilization Market by Product (Reagents, Equipment) by Procedure (ICSI, PGD, FET/FER) by End-user (Fertility and Surgical Centers, Hospitals and Research Laboratories, Cryobanks) by Geography

Request free sample

IVF process involves forcing the production of follicles and eggs through ovulatory simulation, collection of matured eggs, fertilizing them outside the body and then transferring one or more fertilized eggs back into the uterus. With an expected CAGR rise of 12.68%, the Asia-Pacific in-vitro fertilization market continues to escalate in terms of revenue for the forecast period of 2018-2026.

Markets of India, China, Japan, South Korea, Thailand, Australia and the rest of Asia-Pacific are studied for this report.  Japan contributed to the highest revenue share in 2017. However, the Thailand market is expected to rise with the highest CAGR over the forecast period. The overall Asia-Pacific in-vitro fertilization market is supposed to be bolstered by the rising infertility ratio in both male and female population along with the growing medical tourism in the region. Since the cost of these procedures is comparatively less in this region as compared to Europe and North America, the market is also attracting many individuals from countries like Middle East, Africa and Russia.

Some of the bigwig companies that are actively involved in the in-vitro fertilization market include Thermo Fisher Scientific Inc, Halotech DNA, Auxogyn, Ovascience, Copper Surgical Inc, Vitrolife Ab, Cook Medical Inc, Irvine Scientific (Subsidiary Of Nippon Mining Holdings), Genea, Andrology Solutions, Merck Serono, Esco Micro Pte. Ltd, Ivftech Aps, and Ferring Pharmaceuticals.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
    • RESEARCH METHODOLOGY
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • ASIA PACIFIC TO SHOWS GREAT PROMISE OVER THE FORECAST PERIOD
      • INSURANCE COVERAGE FOR IVF
      • GROWTH OF MEDICAL TOURISM
  1. MARKET DYNAMICS
    • MARKET DEFINITION
    • DRIVERS
      • INCREASING RATE OF INFERTILITY ACROSS THE GLOBE
      • FLEXIBLE GOVERNMENT REGULATIONS FOR FERTILITY TOURISM
      • IMPROVED SURROGACY LAWS
      • HIGH SUCCESS RATES OF ADVANCED IN-VITRO FERTILIZATION TREATMENTS
    • RESTRAINTS
      • HIGH COST
      • COUNTRY WISE REGULATORY ISSUES
    • OPPORTUNITIES
      • INCREASING DEMAND FOR LOW-COST PROCEDURES
      • IVF ATTRACTING INVESTMENTS FROM PRIVATE EQUITY INVESTORS
    • CHALLENGES
      • INFERTILITY CONSIDERED A SOCIAL TABOO AMONGST MEN
      • TRADITIONAL TREATMENTS USED WIDELY AS AN ALTERNATIVE TO IVF
        • DIET AND SUPPLEMENTS
        • ACUPUNCTURE
        • THERAPY
        • QIGONG
  1. MARKET BY PRODUCT AND PROCEDURES
    • BY PRODUCT
      • REAGENTS
      • EQUIPMENTS
    • BY PROCEDURE
      • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
      • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
      • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
      • OTHERS
  1. MARKET BY END-USER
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS
  2. KEY ANALYTICS
    • PORTER’S 5 FORCE MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE PRODUCTS
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • VALUE CHAIN ANALYSIS
      • RAW MATERIAL PROCUREMENT
      • MANUFACTURING
      • SUPPLY LOGISTICS
      • DISTRIBUTION CHANNELS
      • END USERS
    • KEY BUYING CRITERIA
      • TREATMENT OPTIONS
      • QUALITY OF MEDICAL PROCEDURES
      • PRICE OF TREATMENTS
      • SHIFT TOWARDS MEDICAL TOURISM
      • REIMBURSEMENT
    • REGULATORY FRAMEWORK
    • INVESTMENT OUTLOOK
      • END-USER OUTLOOK
    • VENDOR LANDSCAPE
    • OPPORTUNITY MATRIX
  3. GEOGRAPHICAL ANALYSIS
    • CHINA
    • INDIA
    • JAPAN
    • SOUTH KOREA
    • AUSTRALIA
    • THAILAND
    • REST OF ASIA-PACIFIC
  4. COMPETITIVE LANDSCAPE
    • MARKET SHARE ANALYSIS
      • VITROLIFE
      • COOPER SURGICAL
      • MERCK
      • COOK MEDICAL
      • FERRING PHARMACEUTICALS
    • TOP WINNING STRATEGIES
    • COMPANY PROFILES
      • ANDROLOGY SOLUTIONS
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • AUXOGYN
        • OVERVIEW
        • PRODUCTS
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • COOK MEDICAL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALY
        • STRATEGIC ANALYSIS
      • COPPER SURGICAL INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • ESCO MICRO PTE. LTD.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • FERRING PHARMACEUTICALS
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • GENEA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • HALOTECH DNA
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • IRVINE SCIENTIFIC (SUBSIDIARY OF NIPPON MINING HOLDINGS)
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • IVFTECH APS
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • MERCK SERONO
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • OVASCIENCE
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • THE BAKER COMPANY, INC.
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • THERMO FISHER SCIENTIFIC INC
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVE
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS
      • VITROLIFE AB
        • OVERVIEW
        • PRODUCT PORTFOLIO
        • STRATEGIC INITIATIVES
        • SCOT ANALYSIS
        • STRATEGIC ANALYSIS

LIST OF TABLES

TABLE 1 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY COUNTRY 2018-2026 ($ MILLION)

TABLE 2 ASIA PACIFIC IVF MARKET BY PRODUCT AND PROCEDURES 2018-2026 ($ MILLION)

TABLE 3 ASIA PACIFIC IVF MARKET BY PRODUCTS 2018-2026 ($ MILLION)

TABLE 4 ASIA PACIFIC IVF MARKET BY PROCEDURE 2018-2026 ($ MILLION)

TABLE 5 ASIA PACIFIC IVF MARKET BY END-USER 2018-2026 ($ MILLION)

TABLE 6 ASIA PACIFIC IVF MARKET BY COUNTRY 2018-2026 ($ MILLION)

 

LIST OF FIGURES

FIGURE 1 ASIA PACIFIC IN-VITRO FERTILIZATION MARKET BY PROCEDURE 2018-2026 ($ MILLION)

FIGURE 2 ASIA PACIFIC IVF MARKET 2018-2026 ($ MILLION)

FIGURE 3 EVOLUTION OF IVF MARKET

FIGURE 4 ASIA PACIFIC REAGENTS MARKET 2018-2026 ($ MILLION)

FIGURE 5 ASIA PACIFIC EQUIPMENTS MARKET 2018-2026 ($ MILLION)

FIGURE 6 ASIA PACIFIC INTRA CYTOPLASMIC SPERM INJECTION (ICSI) MARKET 2018-2026 ($ MILLION)

FIGURE 7 ASIA PACIFIC PRE-IMPLANTATION GENETIC DIAGNOSIS (PGD) MARKET 2018-2026 ($ MILLION)

FIGURE 8 ASIA PACIFIC FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER) MARKET 2018-2026 ($ MILLION)

FIGURE 9 ASIA PACIFIC OTHERS MARKET 2018-2026 ($ MILLION)

FIGURE 10 ASIA PACIFIC FERTILITY AND SURGICAL CENTERS MARKET 2018-2026 ($ MILLION)

FIGURE 11 ASIA PACIFIC HOSPITALS AND RESEARCH LABORATORIES MARKET 2018-2026 ($ MILLION)

FIGURE 12 ASIA PACIFIC CRYOBANKS MARKET 2018-2026 ($ MILLION)

FIGURE 13 INVESTMENT PROPOSITION FOR ASIA PACIFIC IVF MARKET BY END-USER – 2017

FIGURE 14 CHINA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 15 INDIA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 16 JAPAN IVF MARKET 2018-2026 ($ MILLION)

FIGURE 17 SOUTH KOREA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 18 AUSTRALIA IVF MARKET 2018-2026 ($ MILLION)

FIGURE 19 THAILAND IVF MARKET 2018-2026 ($ MILLION)

FIGURE 20 REST OF ASIA-PACIFIC IVF MARKET 2018-2026 ($ MILLION)

FIGURE 21 ASIA PACIFIC IVF MARKET SHARE OF MAJOR COMPANIES – 2017

  1. GEOGRAPHICAL ANALYSIS
    • CHINA
    • INDIA
    • JAPAN
    • SOUTH KOREA
    • AUSTRALIA
    • THAILAND
    • REST OF ASIA-PACIFIC
  2. MARKET BY PRODUCT AND PROCEDURES
    • BY PRODUCT
      • REAGENTS
      • EQUIPMENTS
    • BY PROCEDURE
      • INTRA CYTOPLASMIC SPERM INJECTION (ICSI)
      • PRE IMPLANTATION GENETIC DIAGNOSIS (PGD)
      • FROZEN EMBRYO TRANSFER/REPLACEMENT (FET/FER)
      • OTHERS
  1. MARKET BY END-USER
    • FERTILITY AND SURGICAL CENTERS
    • HOSPITALS AND RESEARCH LABORATORIES
    • CRYOBANKS

To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now